Newsletter | July 27, 2026

07.27.26 -- STREAM New Approaches To Complex Drug Manufacturing

SPONSOR

Implementing Medium And High-Volume Drug Handling And Packaging Programs

Developing a combination drug–delivery product extends far beyond drug development. Pharmaceutical companies must decide whether to use an existing device platform or create a custom solution. While bespoke devices can improve performance and differentiation, they require managing design, manufacturing, assembly, combination product integration, packaging, serialization, release testing, and regulatory compliance. Successfully coordinating these activities is essential before products can enter clinical trials or reach patients in hospitals or home settings. Learn more.

Your Journey To GMP With Emphasis On Linker Payload Development

Webinar | Abzena

Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.

OSD Manufacturing For Pediatrics And Other Special Patient Populations

Webinar | Adare Pharma Solutions

Watch to hear Steven Facer, Adare's Vice President of Business Development EU/ROW, discuss the challenges of pediatric oral solid dose manufacturing and how to overcome them.

Microbial Expertise That Scales Globally

Video | AGC Biologics

Want consistency and control in microbial manufacturing? We combine decades of expertise, advanced automation, and global processes to deliver reliable, scalable fermentation performance.

Spray Dried Biologics For Nasal Dosage Forms

Webinar | Upperton Pharma Solutions

A fireside chat explores spray drying for nasal biologics, covering formulation science, particle design, delivery advantages, and testing strategies to move from concept to clinic.

Start With An Integrated, Verified PFS System

Video | West Pharmaceutical Services, Inc.

Synchrony S1 PFS system delivers an integrated, verified solution designed to streamline submissions, support reliable supply, and reduce development risk.

Modulating Multispecific Manufacturability: A Conversation With AP Biosciences' JJ You, Ph.D.

Video | Bioprocess Online

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Jhong-Jhe You, Ph.D., VP of antibody discovery at AP Biosciences.

SPONSOR

Join this Outsourced Pharma Live discussion: Charting a Direct Pathway from Academia To CDMOs on August 4, 2026 to learn how academic innovators, technology transfer offices, and CDMOs can bridge critical gaps in documentation, quality expectations, and development strategy. Hear practical advice on creating stronger technical packages, aligning earlier with CDMO partners, and accelerating the path from promising research to real-world manufacturing success. Register.

Connect With Outsourced Pharma: